Sep, 26 2019 14:08 JST
Eisai and Fronteo to Launch Coroban Tumbling and Falling Prediction System for Inpatients
TOKYO, Sep, 26 2019 - (JCN Newswire) - Eisai Co., Ltd. and FRONTEO, Inc. announced today that they have launched the tumbling and falling prediction system Coroban to medical institutions in Japan on September 26, 2019. The Coroban predicts inpatients' tumbling and falling risks in advance and displays alerts.
Through the launch of antiosteoporotic agent and insomnia treatment, a pharmaceutical company Eisai has recognized that the preventive measures for tumbling and falling at medical institutions are important. On the other hand, FRONTEO Healthcare, Inc., a wholly owned subsidiary of FRONTEO, is a data analysis corporation focused on healthcare. It has originally developed an artificial intelligence (AI) system called Concept Encoder based on natural language processing technique.
Eisai and FRONTEO have started the joint development for the Coroban since January 2018. The Coroban was introduced to several medical institutions in Japan on a trial basis by leveraging Eisai's network with medical institutions, and advancing the improvements of Coroban based on needs in the clinical settings has led to the launch of the Coroban this time.
According to a survey by the Ministry of Health, Labour and Welfare, the number of inpatients aged 65 and over tends to increase to about 960,000 in 2017, therefore, the importance of cares for tumbling and falling in medical institutions is increasing. The Coroban learns the nursing records of past inpatients at each medical institution, scores the tumbling and falling risks of individual inpatient from the daily nursing records based on these past records, and displays the information of inpatients with high risks. It is expected to reduce the burden of medical professionals and to make the risk assessment uniform and objective by reflecting the information in individual care and nursing plans for each patient's tumbling and falling with the Coroban.
Through the launch of the Coroban which supports to establish systems at nursing ward to reduce the tumbling and falling risks of inpatients, Eisai and Fronteo aim to contribute to the realization of well-being of patients and their families.
About the tumbling and falling prediction system Coroban
Product name: Tumbling and Falling Prediction System Coroban
* The Coroban is not a medical device.
About Concept Encoder AI system
Concept Encoder is the AI system developed by FRONTEO Healthcare. Inc. specifically for the healthcare industry. The system was developed with the aim of effective, evidence-based analysis and utilization of healthcare-related big data, including large bodies of free-entry text data. The program incorporates significance tests and other crucial statistical methods for evidence-based medicine (EBM), the gold standard of practice among healthcare professionals, and applies this to natural language analysis. For more information, visit https://www.fronteo- healthcare.com/conceptencoder.
About FRONTEO, Inc. and FRONTEO Healthcare, Inc.
FRONTEO, Inc. supports the analysis of big data based on behavior informatics by utilizing its originally developed AI technology, "KIBIT". FRONTEO was found in 2003, and has ever since been developing our business primarily in the field of LegalTech including "eDiscovery" (preserve, process review, and analyze electronically stored data that could be evidence doe litigation process) and "digital forensics", as well as initiatives "Securely Identify Risks and Opportunities Buried in Records" in the field of business intelligence. FRONTEO Healthcare, Inc. was found in 2015. Through its data analysis capability, FRONTEO Healthcare, Inc. hopes to support people around the world in receiving the best healthcare services and pave the way to a healthier, more secure future.
For more information about FRONTEO, Inc. and FRONTEO Healthcare, Inc., please visit http://www.fronteo.com/ http://www.fronteo-healthcare.com/
Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Neurology and Oncology.
In its medium-term business plan EWAY2025, Eisai is aiming to become a "Medico Societal Innovator" (a company that changes society through creating medicines and providing solutions), and is working on establishment of ecosystem platform business utilizing various data such as a large amount of clinical data, experiences, and know-how.
For more information about Eisai Co., Ltd., please visit https://www.eisai.co.jp.
Eisai Co., Ltd.
Public Relations Department
Copyright ©2019 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
More Latest Release >>
TOYOTA GAZOO Racing Rally Challenge Program
Dec 13, 2019 18:10 JST
Mitsubishi Corporation Participates in FPSO Project in Brazil
Dec 13, 2019 16:25 JST
Why is Toyota Developing Humanoid Robots?
Dec 13, 2019 13:43 JST
NEC: Demonstration of Secure Data Backup of Medical Records Using Secret Sharing on Secure Communications Network
Dec 12, 2019 16:17 JST
NEC Provides "Waiting Time Forecast System" at Haneda Airport (Tokyo International Airport)
Dec 12, 2019 13:44 JST
Fujitsu Launches New PRIMERGY Model with High-Speed Virtual Switch for 5G Communications in Japan
Dec 12, 2019 13:12 JST
Toyota will Wnveil "GR Yaris" at Tokyo Auto Salon
Dec 11, 2019 17:05 JST
MC: Installation of a Utility-Scale Rooftop Photovoltaic System and Battery Energy Storage System Reusing EV Batteries at Okazaki Plant in Japan
Dec 11, 2019 15:00 JST
Honda Aircraft Company Begins Deliveries of HondaJet Elite to China
Dec 11, 2019 11:50 JST
MHI Thermal Systems to Add 40HP Model to Lineup of "C-puzzle" Refrigeration Condensing Units that Use Natural Refrigerant (CO2)
Dec 11, 2019 11:32 JST
Macau Light Rapid Transit Begins Commercial Operations
Dec 10, 2019 17:07 JST
MIRISE Technologies to be Launched to Develop Semiconductors in Effort to Achieve Safe and Comfortable Future Global Mobility Society
Dec 10, 2019 12:20 JST
Commencement of Major Renovation of Tsukuba Research Laboratories as Eisai Global Drug Discovery Center Aiming for Connecting Human and Human, and Data, and the World
Dec 10, 2019 09:02 JST
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer's Disease Using Blood
Dec 09, 2019 09:36 JST
Eisai Satisfies All-Case Surveillance Condition for Approval of Anti-Cancer Agent Lenvima in Treatment of Thyroid Cancer
Dec 09, 2019 09:17 JST
TOYOTA GAZOO Racing Back in Bahrain
Dec 06, 2019 21:10 JST
Hitachi to Provide CNAO with Proton Therapy System
Dec 06, 2019 19:16 JST
First Trenitalia Chooses Hitachi Rail to Build New Intercity Trains for Avanti West Coast
Dec 06, 2019 19:02 JST
Fujitsu Launches SAP Solution to Support Mass Customization in Engineer-to-Order Production
Dec 06, 2019 18:20 JST
DOCOMO and Kyoto University Develop World's First AI System to Detect Bridge Deterioration using Video-based Vehicle Weights and Structural Deflection
Dec 05, 2019 14:17 JST